KIMS CMD Hails Union Budget’s Duty Exemption on Cancer Drugs, Calls It a Boost for Public Welfare
Dr. Bollineni Bhaskar Rao, Chairman and Managing Director of KIMS Hospitals, has praised key announcements made in the Union Budget 2026-27, highlighting their potential impact on public welfare and national development.
New Delhi: Dr. Bollineni Bhaskar Rao, Chairman and Managing Director of KIMS Hospitals, has praised key announcements made in the Union Budget 2026-27, highlighting their potential impact on public welfare and national development.
Dr. Rao welcomed the government’s decision to exempt basic customs duty on 17 cancer drugs and medicines for seven additional rare diseases, calling it a “highly commendable move” that will reduce treatment costs and improve access to life-saving therapies. He emphasized that this initiative will ease the financial burden on families while allowing doctors to focus entirely on delivering effective patient care.
Follow for more details: munsifdaily.com
In addition, Dr. Rao lauded the continued investment in the country’s infrastructure sector, describing it as a “critical pillar” for building a developed and resilient nation. He noted that robust infrastructure not only drives economic growth but also enhances healthcare delivery, connectivity, and overall quality of life.
“These measures reflect a balanced approach toward social responsibility and long-term national development, placing people at the center of progress,” Dr. Rao said, expressing strong support for the government’s inclusive growth agenda.
